Vaccines are widely regarded as one of the most important public health intervention available. In the last decade, several new vaccines have completed the development process and received approval from regulatory authorities in Europe, the US and elsewhere.
Public procurement and access to vaccines
European Consultation on the modernization of public procurement rules.
EU rules for public procurement
European Commission consultation on the modernization of public procurement rules
EVM reply to the consultation
Quantifying the “Population Access Time” for wew vaccines : a European Comparative Study
A study was conducted in 17 European countries, in order to measure for three recent vaccinations (pneumococcal conjugate, rotavirus and human-papillomavirus) the time between regulatory approval and effective population access, including recommendation and funding (status in July 2009)